DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vfend (Voriconazole) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vfend side effects in 58 year old male

Reported by a physician from United Kingdom on 2012-06-13

Patient: 58 year old male, weighing 78.0 kg (171.6 pounds)

Reactions: Cataract

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-30

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Vfend side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 21 year old male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vfend
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-28
    End date: 2011-12-05

Vfend
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-11-27

Vfend
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-06
    End date: 2011-12-07

Dexamethasone
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-11-27

Nexium
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-11-11

Nexium
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-15
    End date: 2011-12-07

Phenoxymethyl Penicillin
    Dosage: 3 miu iu (10000s), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-18
    End date: 2011-12-07

Daunorubicin Hydrochloride
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27

Daunorubicin Hydrochloride
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-03

Daunorubicin Hydrochloride
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20

Daunorubicin Hydrochloride
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-11

Valacyclovir Hydrochloride
    Dosage: 1 g gram(s), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13
    End date: 2011-12-07

Vincristine Sulfate
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20

Vincristine Sulfate
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-03

Vincristine Sulfate
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27

Vincristine Sulfate
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-10

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-10

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-16

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-03

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-13

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-06

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-24

Kidrolase
    Dosage: see image
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-30



Possible Vfend side effects in male

Reported by a physician from France on 2012-05-25

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3iu6 per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-18
    End date: 2011-12-07

Nexium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Vfend
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-17
    End date: 2011-12-07

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-27

Valacyclovir Hydrochloride
    Dosage: 1g per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13
    End date: 2011-12-07

Kidrolase
    Dosage: 10iu3 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Cerubidine
    Dosage: 60mg cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine



Possible Vfend side effects in 21 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24

Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Start date: 2011-10-17
    End date: 2011-12-07

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Valacyclovir Hydrochloride
    Dosage: 1 g, 1x/day
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-27

Cerubidine
    Dosage: 60 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Phenoxymethyl Penicillin
    Dosage: 3 millioniu, 1x/day
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-20
    End date: 2011-11-10

Nexium
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Kidrolase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-10-24
    End date: 2011-11-16

Other drugs received by patient: Cyclophosphamide; Cytarabine; Methotrexate



Possible Vfend side effects in male

Reported by a physician from France on 2012-05-23

Patient: male

Reactions: Toxic Optic Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-27

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-24

Vfend
    Start date: 2011-10-17
    End date: 2011-11-27

Valacyclovir Hydrochloride
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-10

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-10

Vfend
    Start date: 2011-11-28
    End date: 2011-12-05

Dexamethasone
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-20
    End date: 2011-11-27

Phenoxymethyl Penicillin
    Dosage: 3 000 000 iu
    Administration route: Oral
    Start date: 2011-11-18
    End date: 2011-12-07

Kidrolase
    Start date: 2011-10-27

Kidrolase
    Start date: 2011-11-16

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-11-03

Nexium
    Dosage: daily
    Administration route: Oral
    Start date: 2011-10-17
    End date: 2011-11-11

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-11-03

Kidrolase
    Start date: 2011-11-10

Kidrolase
    Start date: 2011-11-13

Kidrolase
    Start date: 2011-11-06

Nexium
    Administration route: Oral
    Start date: 2011-11-15
    End date: 2011-12-07

Vfend
    Start date: 2011-12-06
    End date: 2011-12-07

Vincristine
    Dosage: 2 mg per course
    Start date: 2011-10-20

Kidrolase
    Start date: 2011-10-30

Kidrolase
    Start date: 2011-11-03

Cerubidine
    Dosage: 60 mg per course
    Start date: 2011-10-27



Possible Vfend side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22

Patient: 66 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Peripheral Sensory Neuropathy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Cacit D3; Actonel



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-02

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Hepatic Function Abnormal, Renal Impairment, Pancytopenia

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-13
    End date: 2011-01-13

Vfend
    Dosage: 220 mg, bid
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-11
    End date: 2011-04-09

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-04-10
    End date: 2011-05-16

Funguard
    Dosage: 150 mg, uid/qd
    Indication: Fungal Rhinitis
    Start date: 2010-12-18
    End date: 2011-04-12

Vfend
    Dosage: 300 mg, bid
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-25

Funguard
    Indication: Cranial Nerve Disorder

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-20
    End date: 2011-01-20

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-17
    End date: 2011-02-17

Ambisome
    Dosage: 120 mg, uid/qd
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-30

Ambisome
    Dosage: 165 mg, uid/qd
    Start date: 2010-12-01
    End date: 2010-12-10

Vfend
    Dosage: 200 mg, bid
    Start date: 2010-12-02
    End date: 2011-01-10

Vfend
    Dosage: 300 mg, bid
    Administration route: Oral
    Start date: 2011-04-09
    End date: 2011-04-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-09
    End date: 2011-02-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-03
    End date: 2011-02-03

Ambisome
    Dosage: 220 mg, uid/qd
    Indication: Cranial Nerve Disorder
    Start date: 2010-12-11
    End date: 2011-04-08

Funguard
    Indication: Systemic Mycosis

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Fungal Infection
    Start date: 2011-01-06
    End date: 2011-01-06

Other drugs received by patient: Epinastine Hydrochloride; Metformin HCL; Hydrocortisone Sodium Succinate; Humalog; Actos; Lantus; Meropenem; Kinedak



Possible Vfend side effects in 12 year old female

Reported by a physician from Japan on 2012-03-13

Patient: 12 year old female

Reactions: Nephrotic Syndrome

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Vfend
    Dosage: 400 mg, 2x/day
    Start date: 2010-12-01
    End date: 2010-12-16

Vfend
    Dosage: 600 mg, 2x/day
    Start date: 2011-01-29
    End date: 2011-02-08

Vfend
    Dosage: 200 mg, 2x/day
    Start date: 2010-11-08
    End date: 2010-11-08

Vfend
    Dosage: 800 mg, 2x/day
    Start date: 2011-01-10
    End date: 2011-01-26

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Infection
    Start date: 2010-10-15
    End date: 2010-10-28

Vfend
    Dosage: 240 mg, 2x/day
    Start date: 2010-11-09
    End date: 2010-11-09

Vfend
    Dosage: 340 mg, 2x/day
    Start date: 2010-11-30
    End date: 2010-11-30

Vfend
    Dosage: 280 mg, 2x/day
    Start date: 2010-11-10
    End date: 2010-11-29

Vfend
    Dosage: 600 mg, 2x/day
    Start date: 2010-12-17
    End date: 2011-01-10

Vfend
    Dosage: 700 mg, 2x/day
    Start date: 2011-01-27
    End date: 2011-01-28

Vfend
    Dosage: 700 mg, 2x/day
    Start date: 2011-02-09
    End date: 2011-02-17

Sandimmune
    Dosage: unk
    Indication: Aplastic Anaemia

Other drugs received by patient: Micafungin Sodium; Cotrim; Polymyxin B Sulfate



Possible Vfend side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-17

Patient: 66 year old female

Reactions: Peripheral Sensory Neuropathy

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Actonel; Calcium Carbonate



Possible Vfend side effects in 58 year old male

Reported by a pharmacist from Japan on 2011-10-28

Patient: 58 year old male, weighing 43.3 kg (95.3 pounds)

Reactions: Sepsis, Hypoglycaemia, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Vfend
    Dosage: 6 mg/kg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2011-07-29
    End date: 2011-07-29

Vfend
    Dosage: 4 mg/kg, 2x/day
    Start date: 2011-07-30
    End date: 2011-08-06

Selegiline HCL
    Dosage: 2.5 mg, 2x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2011-08-06

Other drugs received by patient: Requip; Bladderon; Dops; Madopar; Comtan



Possible Vfend side effects in 58 year old male

Reported by a physician from Japan on 2011-10-14

Patient: 58 year old male, weighing 43.3 kg (95.3 pounds)

Reactions: Sepsis, Hypoglycaemia, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Vfend
    Dosage: 6 mg/kg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2011-07-29
    End date: 2011-07-29

Vfend
    Dosage: 4 mg/kg, 2x/day
    Start date: 2011-07-30
    End date: 2011-08-06

Selegiline HCL
    Dosage: 2.5 mg, 2x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2011-08-06

Other drugs received by patient: Requip; Comtan; Dops; Madopar; Bladderon



Possible Vfend side effects in 58 year old male

Reported by a physician from Japan on 2011-10-12

Patient: 58 year old male, weighing 43.3 kg (95.3 pounds)

Reactions: Hypoglycaemia, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Vfend
    Dosage: 6 mg/kg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2011-07-29
    End date: 2011-07-29

Vfend
    Dosage: 4 mg/kg, 2x/day
    Start date: 2011-07-30
    End date: 2011-08-06

Selegiline HCL
    Dosage: 2.5 mg, 2x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2011-08-06

Other drugs received by patient: Madopar; Bladderon; Dops; Comtan; Requip

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014